Prostaglandin E2 Reverses Aberrant Production of an Inflammatory Chemokine by Microglia from Sandhoff Disease Model Mice through the cAMP-PKA Pathway Down-Regulation of MIP-1 by PGE2 in SD Microglia
2011
Prostaglandin E2 Reduces Inflammatory Chemokine Production in Sandhoff Disease Model Mice
publication
Evidence: moderate
Author Information
Author(s): Kawashita Eri, Tsuji Daisuke, Toyoshima Masahiro, Kanno Yosuke, Matsuno Hiroyuki, Itoh Kohji
Primary Institution: The University of Tokushima
Hypothesis
Can prostaglandin E2 (PGE2) suppress the production of MIP-1α in microglia from Sandhoff disease model mice?
Conclusion
PGE2 acts as a negative regulator of MIP-1α production in microglia from Sandhoff disease model mice.
Supporting Evidence
- PGE2 reduced MIP-1α production by SD-Mg to the same level as by WT-Mg.
- PGE2 attenuated the activation of Akt and JNK in microglia.
- The inhibition of MIP-1α production occurred through the EP2 and 4/cAMP/PKA signaling pathway.
Takeaway
This study shows that a substance called PGE2 can help reduce a harmful protein in brain cells of mice with a disease called Sandhoff disease.
Methodology
The study involved treating microglial cells from Sandhoff disease model mice with PGE2 and measuring the production of MIP-1α and the activation of signaling pathways.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website